Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.312381
Title: p53 epitopes as potential tumour targets for immunotherapy programmes against cancers
Author: McArdle, Stephanie
Awarding Body: University of Sheffield
Current Institution: University of Sheffield
Date of Award: 2000
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
The tumour suppressor gene p53 is pivotal in the regulation of program cell death (apoptosis), and point mutations within the gene represent the most common genetic alterations in human cancers. This process can result in the overexpression and/or accumulation of mutated and/or wild-type p53 protein within the cell. Cytotoxic T lymphocytes (CTL) play a critical role in the immune defense by recognising peptide/MHC complexes on the surface of virally infected or tumour cells followed by lysis. Therefore, p53-derived peptides are potential candidates for immunisation strategies designed to induce anti-tumour CTL in patients.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.312381  DOI: Not available
Keywords: Suppressor genes; Apoptosis
Share: